<p>According to the Cuban government, its <strong>Abdala</strong> coronavirus vaccine has shown 92.28 per cent efficacy in the last stage of clinical trials.</p>

<p>"It has great scientific relevance and a potential medical impact. Just ten&nbsp;months after initiating the projects in the laboratories of the CIGB (Genetic Engineering and Biotechnology Centre) and the Finlay vaccine institute," Rolando Perez, Cuba's director of science and innovation of <strong>Biocubafarma</strong>, said.</p>

<p><strong>Watch:</strong></p>

<div class="videoWrapper trancodeVideo"><iframe allowfullscreen="" autoplay="1" class="includeVideo" frameborder="0" height="350" src="https://www.wionews.com/videos/covid-vaccine-technology-transfer-center-to-open-in-sa-393047/embed" style="width:100%;max-width:560px;" width="560"></iframe></div>

<p>Rolando Perez added that <strong>efficacy</strong> data of the vaccine was achieved in a complex "epidemiological scenario". Abdala is a three-shot vaccine.</p>

<p>BioCubaFarma laboratory in a tweet earlier had said Abdala had shown an "efficacy of 92.28 per cent in its three-dose scheme".</p>

<div class="ui-state-default" contenteditable="false">
<div class="twitter-block" draggable="false">
<blockquote class="twitter-tweet">
<p dir="ltr" lang="es"><a href="https://twitter.com/hashtag/Abdala?src=hash&amp;ref_src=twsrc%5Etfw">#Abdala</a> candidato vacunal del <a href="https://twitter.com/CIGBCuba?ref_src=twsrc%5Etfw">@CIGBCuba</a>, muestra una eficacia del 92, 28 %, en su esquema de 3 dosis. <a href="https://twitter.com/hashtag/CubaEsCiencia?src=hash&amp;ref_src=twsrc%5Etfw">#CubaEsCiencia</a> <a href="https://t.co/pLxPYthz3X">pic.twitter.com/pLxPYthz3X</a></p>
— BioCubaFarma (@BioCubaFarma) <a href="https://twitter.com/BioCubaFarma/status/1407113443304521728?ref_src=twsrc%5Etfw">June 21, 2021</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<a class="close-mark close-div" href="#" id="jqclosemark">×</a></div>

<p>The government had said earlier announced that its vaccine <a href="https://www.wionews.com/world/cuba-encouraged-by-early-efficacy-results-of-homegrown-covid-19-vaccine-392671">Soberana 2</a> had achieved 62 per cent efficacy with two or three doses.</p>

<p>Reports say both Soberana 2 and Abdala are set to be approved by <strong>Cuban</strong> health regulators for coronavirus treatment.</p>

<p>The country has already started using the Abdala vaccine even as it has rejected foreign vaccines. Reports say nearly one million people have already been <strong>vaccinated</strong>.</p>

<p>Several countries including Venezuela, <strong>Vietnam</strong>, Argentina and <strong>Mexico</strong> have reportedly expressed an interest in buying the vaccines produced by Cuba.</p>

<p>The virus has so far infected just 169,365 citizens in the country with 1,170 fatalities, however, Cuba&nbsp;has experienced a surge in cases recently. On Monday, the country recorded 1,561 COVID-19 cases worrying health officials.</p>

<p><em>(With inputs from Agencies)</em></p>


According to the Cuban government, its Abdala coronavirus vaccine has shown 92.28 per cent efficacy in the last stage of clinical trials. "It has great scientific relevance and a potential medical impact.

According to the Cuban government, its Abdala coronavirus vaccine has shown 92.28 per cent efficacy in the last stage of clinical trials. "It has great scientific relevance and a potential medical impact. Just ten months after initiating the projects in the laboratories of the CIGB (Genetic Engineering and Biotechnology Centre) and the Finlay vaccine institute," Rolando Perez, Cuba's director of science and innovation of Biocubafarma, said. Watch: Rolando Perez added that efficacy data of the vaccine was achieved in a complex "epidemiological scenario". Abdala is a three-shot vaccine. BioCubaFarma laboratory in a tweet earlier had said Abdala had shown an "efficacy of 92.28 per cent in its three-dose scheme". #Abdala candidato vacunal del @CIGBCuba, muestra una eficacia del 92, 28 %, en su esquema de 3 dosis. #CubaEsCiencia pic.twitter.com/pLxPYthz3X — BioCubaFarma (@BioCubaFarma) June 21, 2021 × The government had said earlier announced that its vaccine Soberana 2 had achieved 62 per cent efficacy with two or three doses. Reports say both Soberana 2 and Abdala are set to be approved by Cuban health regulators for coronavirus treatment. The country has already started using the Abdala vaccine even as it has rejected foreign vaccines. Reports say nearly one million people have already been vaccinated. Several countries including Venezuela, Vietnam, Argentina and Mexico have reportedly expressed an interest in buying the vaccines produced by Cuba. The virus has so far infected just 169,365 citizens in the country with 1,170 fatalities, however, Cuba has experienced a surge in cases recently. On Monday, the country recorded 1,561 COVID-19 cases worrying health officials. (With inputs from Agencies)

Abdala vaccine 92.28% effective against COVID-19, says Cuba

soberana-2-vaccine

Soberana 2 Vaccine, News on Soberana 2 Vaccine, stories on Soberana 2 Vaccine, articles on Soberana 2 Vaccine, Soberana 2 Vaccine stories at Wion, Soberana 2 Vaccine news, Soberana 2 Vaccine latest news

soberana 2-vaccine

Abdala vaccine 92.28% effective against COVID-19, says Cuba